Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs

References

• WrightJRUngYCJulianJARandomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemiaJ Clin Oncol20072591027103217312332
   PubMed Web of Science ®Google Scholar
• AupérinALe PéchouxCRollandEMeta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancerJ Clin Oncol201028132181219020351327
   PubMed Web of Science ®Google Scholar
• WangRHuHPanYRET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancerJ Clin Oncol201230354352435923150706
   PubMed Web of Science ®Google Scholar
• RansonMDavidsonNNicolsonMRandomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancerJ Natl Cancer Inst200092131074108010880550
   PubMed Web of Science ®Google Scholar
• ScagliottiGNovelloSvon PawelJPhase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancerJ Clin Oncol201028111835184220212250
   PubMed Web of Science ®Google Scholar
• FossellaFPereiraJRvon PawelJRandomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study groupJ Clin Oncol200321163016302412837811
   PubMed Web of Science ®Google Scholar
• GervaisRDucoloneABretonJLPhase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)Ann Oncol2005161909615598944
   PubMed Web of Science ®Google Scholar
• ScagliottiGVPastorinoUVansteenkisteJFRandomized phase III study of surgery alone or surgery plus preoperative cisplatin and gem-citabine in stages IB to IIIA non-small-cell lung cancerJ Clin Oncol201230217217822124104
   PubMed Web of Science ®Google Scholar
• LiuYPYangCJHuangMSCisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signalingCancer Res201373140641623135908
   PubMed Web of Science ®Google Scholar
• SequistLVMartinsRGSpigelDFirst-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutationsJ Clin Oncol200826152442244918458038
   PubMed Web of Science ®Google Scholar
• MokTSWuYLThongprasertSGefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaN Engl J Med20093611094795719692680
   PubMed Web of Science ®Google Scholar
• ZhangLMaSSongXINFORM investigatorsGefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trialLancet Oncol201213546647522512843
   PubMed Web of Science ®Google Scholar
• Phillip LeeYHSathigariSJean LinYJGefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studiesDrug Dev Ind Pharm20093591113112019640249
   PubMed Web of Science ®Google Scholar
• ChitkaraDSinghSKumarVMicellar delivery of cyclopamine and gefitinib for treating pancreatic cancerMol Pharm2012982350235722780906
   PubMedGoogle Scholar
• GoduguCDoddapaneniRPatelARSinghRMercerRSinghMNovel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin CarcinomaPharm Res201633113715426286185
   PubMed Web of Science ®Google Scholar
• EdaGChhowallaMChemically derived graphene oxide: towards large-area thin-film electronics and optoelectronicsAdv Mater201022222392241520432408
   PubMed Web of Science ®Google Scholar
• ComptonOCJainBDikinDAAbouimraneAAmineKNguyenSTChemically active reduced graphene oxide with tunable C/O ratiosACS Nano2011564380439121473647
   PubMed Web of Science ®Google Scholar
• ShengZHShaoLChenJJBaoWJWangFBXiaXHCatalyst-free synthesis of nitrogen-doped graphene via thermal annealing graphite oxide with melamine and its excellent electrocatalysisACS Nano2011564350435821574601
   PubMed Web of Science ®Google Scholar
• MaXTaoHYangKA functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imagingNano Res201253199212
   Web of Science ®Google Scholar
• WangZDongYLiHEnhancing lithium-sulphur battery performance by strongly binding the discharge products on amino-functionalized reduced graphene oxideNat Commun20145500225255431
   PubMed Web of Science ®Google Scholar
• SunXLiuZWelsherKNano-graphene oxide for cellular imaging and drug deliveryNano Res20081320321220216934
   PubMed Web of Science ®Google Scholar
• SongEHanWLiCHyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug deliveryACS Appl Mater Interfaces2014615118821189025000539
   PubMed Web of Science ®Google Scholar
• SuraceCArpiccoSDufaÿ-WojcickiALipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cellsMol Pharm2009641062107319413341
   PubMedGoogle Scholar
• HuangYYaoXZhangRCationic conjugated polymer/fluo-resceinamine-hyaluronan complex for sensitive fluorescence detection of CD44 and tumor-targeted cell imagingACS Appl Mater Interfaces2014621191441915325278260
   PubMed Web of Science ®Google Scholar
• DreadenECMortonSWShopsowitzKEBimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticlesACS Nano2014888374838225100313
   PubMed Web of Science ®Google Scholar
• WenHDongCDongHEngineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug deliverySmall20128576076922228696
   PubMed Web of Science ®Google Scholar
• SchaferFQBuettnerGRRedox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione coupleFree Radic Biol Med200130111191121211368918
   PubMed Web of Science ®Google Scholar
• ZhaoQGengHWangYHyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug deliveryACS Appl Mater Interfaces2014622202902029925311422
   PubMed Web of Science ®Google Scholar
• MaYCWangJXTaoWRedox-Responsive Polyphosphoester-Based Micellar Nanomedicines for Overriding Chemoresistance in Breast Cancer CellsACS Appl Mater Interfaces2015747263152632526552849
   PubMed Web of Science ®Google Scholar
• PanYJChenYYWangDRRedox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug releaseBiomaterials201233276570657922704845
   PubMed Web of Science ®Google Scholar
• ChengRFengFMengFDengCFeijenJZhongZGlutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryJ Control Release2011152121221295087
   PubMed Web of Science ®Google Scholar
• MarcanoDCKosynkinDVBerlinJMImproved synthesis of graphene oxideACS Nano2010484806481420731455
   PubMed Web of Science ®Google Scholar
• LiuZRobinsonJTSunXDaiHPEGylated nanographene oxide for delivery of water-insoluble cancer drugsJ Am Chem Soc200813033108761087718661992
   PubMed Web of Science ®Google Scholar
• WangJChengMZhangZGuoLLiuQJiangGAn antibody-graphene oxide nanoribbon conjugate as a surface enhanced laser desorption/ionization probe with high sensitivity and selectivityChem Commun2015512246194622
   PubMed Web of Science ®Google Scholar
• HuangPXuCLinJFolic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic TherapyTheranostics2011124025021562631
   PubMed Web of Science ®Google Scholar
• RenWFangYWangEA binary functional substrate for enrichment and ultrasensitive SERS spectroscopic detection of folic acid using graphene oxide/Ag nanoparticle hybridsACS Nano2011586425643321721545
   PubMed Web of Science ®Google Scholar
• ZhouTZhouXXingDControlled release of doxorubicin from graphene oxide based charge-reversal nanocarrierBiomaterials201435134185419424513318
   PubMed Web of Science ®Google Scholar
• DuchMCBudingerGRLiangYTMinimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lungNano Lett201111125201520722023654
   PubMed Web of Science ®Google Scholar
• ZhangLXiaJZhaoQLiuLZhangZFunctional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugsSmall20106453754420033930
   PubMed Web of Science ®Google Scholar
• DongHGaoWYanFJiHJuHFluorescence resonance energy transfer between quantum dots and graphene oxide for sensing biomoleculesAnal Chem201082135511551720524633
   PubMed Web of Science ®Google Scholar
• ShenLLiZShenSThe synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell linesLung Cancer201278319320022985911
   PubMed Web of Science ®Google Scholar
• RhoJKChoiYJRyooBYp53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancerCancer Res20076731163116917283151
   PubMed Web of Science ®Google Scholar
• SharmaJLvHGalloJMIntratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastomaCancer Res201373165242525223796561
   PubMed Web of Science ®Google Scholar